REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Terawins, Inc. (Taiwan, China)

Main Activities: Research and Development in Nanotechnology
Full name: Terawins, Inc. Profile Updated: August 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Terawins, Inc. designs and sells liquid crystal thin film display control chips. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Headquarters
6F-4.,No.186,Jian 1St Rd, Zhonghe Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Terawins, Inc. report to view the information.

Website: http://www.terawins.com.tw

Basic Information
Total Employees:
Purchase the Terawins, Inc. report to view the information.
Outstanding Shares:
Purchase the Terawins, Inc. report to view the information.
Financial Auditors:
Purchase the Terawins, Inc. report to view the information.
Incorporation Date:
December 19, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
17.65%
Purchase this report to view the information.
8.19%
Purchase this report to view the information.
7.6%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Terawins Holding, Inc
100%
Company Performance
Financial values in the chart are available after Terawins, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-16.16%▼
Total operating revenue
-16%▼
Operating profit (EBIT)
54.68%▲
EBITDA
57.39%▲
Net Profit (Loss) for the Period
58.61%▲
Total assets
-34.51%▼
Total equity
-39.17%▼
Operating Profit Margin (ROS)
36.06%▲
Net Profit Margin
41.23%▲
Return on Equity (ROE)
4.94%▲
Debt to Equity Ratio
9.31%▲
Quick Ratio
-2.77%▼
Cash Ratio
-1.03%▼

Similar companies

Applied BioCode Corporation
 
Foresee Pharmaceuticals Co., Ltd.
Pell Bio-Med Technology Co. Ltd.
 
Steminent Biotherapeutics Inc.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo